Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVI-CO-004 multiple-dose trial in male HIV-1 infected subjects
KCT0005329Phase 2Not yet recruiting
- Sponsor
- Avixgen
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AVI-CO-004 in Human immunodeficiency virus infection type 1, sponsored by Avixgen. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
AVI-CO-004
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on KCT0005329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005329.